Golden Lee Scott 4
4 · PTC THERAPEUTICS, INC. · Filed Apr 6, 2026
Research Summary
AI-generated summary of this filing
PTC Therapeutics EVP/CMO Golden Lee Scott Sells 829 Shares
What Happened
Golden Lee Scott, EVP and Chief Medical Officer of PTC Therapeutics (PTCT), sold 829 shares on 2026-04-02 at $67.99 per share, for a total value of $56,364. The sale was a sell-to-cover transaction tied to RSU vesting (not a discretionary market-timing sale).
Key Details
- Transaction date and price: 2026-04-02 — 829 shares sold at $67.99 each.
- Total proceeds: $56,364.
- Shares owned after transaction: Not reported in the Form 4 filing.
- Footnote: The shares were automatically sold pursuant to an irrevocable sell-to-cover election to satisfy tax withholding for the vesting of 2,100 RSUs from an April 24, 2023 grant of 8,400 RSUs.
- Filing timeliness: Report filed 2026-04-06, within the required two business days (timely).
Context
A sell-to-cover is a routine automatic sale to cover tax obligations when RSUs vest; it generally reflects tax logistics rather than a change in the insider's view of the company. This was a sale (code S) tied to tax withholding, not a purchase or speculative move.
Insider Transaction Report
Form 4
Golden Lee Scott
EVP & CHIEF MEDICAL OFFICER
Transactions
- Sale
Common Stock
[F1]2026-04-02$67.99/sh−829$56,364→ 79,115 total
Footnotes (1)
- [F1]Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 2,100 RSUs from an April 24, 2023 grant of 8,400 RSUs.
Signature
/s/ Avraham S. Adler, Attorney-in-Fact|2026-04-06